You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Talzenna

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Korea Post Marketing Surveillance (PMS) Study of Talzenna®

Not yet recruiting
  • Breast Neoplasms
  • Talzenna
  • (no location specified)
Aug 1, 2022

Acute Myeloid Leukemia Trial (NK cells, Talazoparib 1 MG [Talzenna])

Not yet recruiting
  • Acute Myeloid Leukemia
  • NK cells
  • Talazoparib 1 MG [Talzenna]
  • (no location specified)
Jan 9, 2023

Breast Cancer, Advanced Breast Cancer Trial in Stanford (Talazoparib Tosylate)

Not yet recruiting
  • Breast Cancer
  • Advanced Breast Cancer
  • Talazoparib Tosylate
  • Stanford, California
    Stanford University
Nov 9, 2022

Breast Cancer Trial in Washington, Charlotte, Salt Lake City (Talazoparib, Avelumab)

Active, not recruiting
  • Breast Cancer
  • Washington, District of Columbia
  • +1 more
Oct 10, 2022

Metastatic or Unresectable Melanoma Trial in Cleveland (Nivolumab, Talazoparib)

Recruiting
  • Metastatic or Unresectable Melanoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Mar 22, 2022

BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer Trial in Providence (Talazoparib Oral Capsule)

Active, not recruiting
  • BRCA1 Mutation
  • +4 more
  • Talazoparib Oral Capsule
  • Providence, Rhode Island
  • +1 more
Nov 30, 2022

Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Boston (Talazoparib, Tazemetostat)

Recruiting
  • Metastatic Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • Boston, Massachusetts
  • +1 more
Jul 18, 2022

Among Talazoparib-Treated HER2-Negative mBC With gBRCA1/2m

Completed
  • Metastatic Breast Cancer
  • Breast Neoplasms
  • New York, New York
    Pfizer Inc.
Aug 5, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Baltimore, Buffalo (Gemtuzumab Ozogamicin,

Recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Gemtuzumab Ozogamicin
  • +4 more
  • Baltimore, Maryland
  • +1 more
Dec 13, 2022

Breast Cancer, Triple Negative Breast Cancer Trial in United States (Capecitabine, Talazoparib, Atezolizumab)

Recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Washington, District of Columbia
  • +5 more
Jan 12, 2023

US Talazoparib-Treated Locally Advanced or Metastatic Breast

Completed
  • Breast Cancer
  • New York, New York
    Pfizer Inc
Nov 22, 2021

Advanced Cancer, Metastatic Cancer, Breast Cancer Trial in United Kingdom, United States (ART4215, Talazoparib, Niraparib)

Recruiting
  • Advanced Cancer
  • +2 more
  • Orlando, Florida
  • +6 more
Aug 16, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Axitinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021

Solid Tumor, Clear Cell Renal Cell Carcinoma, TNBC - Triple-Negative Breast Cancer Trial in United States (CB-839, Talazoparib)

Terminated
Has Results
  • Solid Tumor
  • +6 more
  • Birmingham, Alabama
  • +8 more
Feb 16, 2022

Squamous Cell Carcinoma of the Head and Neck (SCCHN), Metastatic Castration Resistant Prostate Cancer (mCRPC) Trial in Worldwide

Terminated
Has Results
  • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • Rochester, New York
  • +4 more
Sep 17, 2021

Endometrial Cancer Trial in United States (Atezolizumab - 28 Day Cycle, Bevacizumab, Ipatasertib)

Recruiting
  • Endometrial Cancer
  • Atezolizumab - 28 Day Cycle
  • +6 more
  • Duarte, California
  • +13 more
Jun 8, 2022

Recurrent Solid Tumor, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Canada, United States (Onivyde, Talazoparib,

Recruiting
  • Recurrent Solid Tumor
  • +21 more
  • Palo Alto, California
  • +8 more
Jun 7, 2022

Advanced Malignant Solid Tumor, Clinical Stage III Gastroesophageal Junction Adenocarcinoma, Clinical Stage IV Gastroesophageal

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +28 more
  • Trifluridine and Tipiracil Hydrochloride
  • Talazoparib Tosylate
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 2, 2022

HRD 100 Gene Expression High, Triple Negative Breast Cancer Trial in Kuala Lumpur (Talazoparib)

Recruiting
  • HRD 100 Gene Expression High
  • Triple Negative Breast Cancer
  • Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia
    University Malaya Medical Centre
Mar 15, 2022

Advanced Solid Tumors, Solid Tumors, Ovarian Cancer Trial in Australia, United States (TALZENNA capsule, Talazoparib soft gel

Active, not recruiting
  • Advanced Solid Tumors
  • +7 more
  • TALZENNA capsule
  • Talazoparib soft gel capsule
  • Encinitas, California
  • +31 more
Feb 14, 2022

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Birmingham, Alabama
  • +125 more
Nov 21, 2022

Cancer, Advanced Solid Tumor Trial in Kettering (lorlatinib, encorafenib + binimetinib, talazoparib)

Recruiting
  • Cancer
  • Advanced Solid Tumor
  • Kettering, Ohio
    Kettering Health Network
Oct 14, 2022

Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer

Active, not recruiting
  • Advanced Lung Non-Squamous Non-Small Cell Carcinoma
  • +4 more
  • Mobile, Alabama
  • +324 more
Sep 21, 2021